Latest Period
Q4 2025
CUSIP: 433313103
Latest Period
Q4 2025
Institutions Reporting
181
Shares (Excl. Options)
50,871,051
Price
$46.45
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 181 institutions filings for Q4 2025.
What is CUSIP 433313103?
CUSIP 433313103 identifies HNGE - Hinge Health, Inc. - Class A Common Stock, par value $0.00001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 433313103:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Perez Daniel Antonio | 16% | -45% | $509,746,419 | -$8,764,119 | 10,373,350 | -1.7% | Daniel Antonio Perez | 31 Dec 2025 |
| Insight Holdings Group, LLC | 20% | -31% | $460,695,559 | -$81,299,182 | 9,375,164 | -15% | Insight Venture Associates X, L.P. | 31 Dec 2025 |
| Atomico Advisors IV, Ltd. | 5.1% | -40% | $136,798,709 | -$85,068,023 | 4,139,144 | -38% | Atomico Advisors IV, Ltd. | 18 Nov 2025 |
| Mecklenburg Gabriel M.I. | 13% | $177,706,007 | 4,025,963 | Gabriel M.I. Mecklenburg | 30 Jun 2025 | |||
| 11.2 Capital I, L.P. | 9.8% | -19% | $182,040,309 | 3,704,524 | 0% | Qian Zhuang | 31 Dec 2025 | |
| Bessemer Venture Partners X L.P. | 8.3% | -37% | $153,990,362 | -$47,911,500 | 3,133,707 | -24% | Deer X & Co. L.P. | 31 Dec 2025 |
| VANGUARD GROUP INC | 6.9% | $120,982,928 | 2,605,532 | The Vanguard Group | 31 Dec 2025 | |||
| HANSAINVEST Hanseatische Investment-Limited Co | 5.7% | $100,159,493 | 2,157,071 | HANSAINVEST Hanseatische Investment-Limited Co | 31 Dec 2025 | |||
| JANE STREET GROUP, LLC | 4.2% | -23% | $73,764,133 | -$25,146,774 | 1,588,611 | -25% | JANE STREET GROUP, LLC | 31 Dec 2025 |
| Alyeska Investment Group, L.P. | 4.8% | -13% | $63,460,784 | -$3,438,250 | 1,293,007 | -5.1% | Alyeska Investment Group, L.P. | 30 Sep 2025 |
| ALKEON CAPITAL MANAGEMENT LLC | 2.1% | -60% | $38,874,851 | -$39,312,000 | 791,104 | -50% | Alkeon Capital Management LLC | 31 Dec 2025 |
As of 31 Dec 2025, 181 institutional investors reported holding 50,871,051 shares of Hinge Health, Inc. - Class A Common Stock, par value $0.00001 per share (HNGE). This represents 63% of the company’s total 81,159,686 outstanding shares.
The largest institutional shareholders of Hinge Health, Inc. - Class A Common Stock, par value $0.00001 per share (HNGE) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Insight Holdings Group, LLC | 12% | 9,375,164 | -15% | 33% | $435,476,368 |
| 11.2 CAPITAL MANAGEMENT, LLC | 4.6% | 3,704,524 | 0% | 100% | $172,075,140 |
| BIT Capital GmbH | 4.1% | 3,316,101 | +79% | 6.7% | $154,032,891 |
| VANGUARD GROUP INC | 3.2% | 2,605,532 | +110% | 0% | $121,026,961 |
| TIGER GLOBAL MANAGEMENT LLC | 2.2% | 1,805,751 | +227% | 0.28% | $83,877,134 |
| JANE STREET GROUP, LLC | 1.9% | 1,566,811 | +3371% | 0.09% | $72,778,371 |
| MILLENNIUM MANAGEMENT LLC | 1.8% | 1,479,642 | +193% | 0.05% | $68,729,371 |
| BRAIDWELL LP | 1.6% | 1,304,623 | +43% | 1.9% | $60,599,738 |
| ArrowMark Colorado Holdings LLC | 1.6% | 1,273,510 | +163% | 1.3% | $59,154,540 |
| Vitruvian Partners LLP | 1.5% | 1,250,000 | 0% | 42% | $58,062,500 |
| Alyeska Investment Group, L.P. | 1.5% | 1,226,972 | -5.1% | 0.16% | $56,992,849 |
| MARSHALL WACE, LLP | 1.4% | 1,172,631 | 0.05% | $54,468,710 | |
| BAMCO INC /NY/ | 1.2% | 999,570 | +5.8% | 0.13% | $46,430,026 |
| BlackRock, Inc. | 1% | 824,391 | +41% | 0% | $38,292,961 |
| ALKEON CAPITAL MANAGEMENT LLC | 0.97% | 791,104 | +110% | 0.16% | $36,746,781 |
| JPMORGAN CHASE & CO | 0.97% | 790,915 | +6.3% | 0% | $36,738,001 |
| MORGAN STANLEY | 0.93% | 757,781 | +271% | 0% | $35,198,928 |
| BNP PARIBAS FINANCIAL MARKETS | 0.9% | 727,672 | 0% | 0.02% | $33,800,364 |
| LORD, ABBETT & CO. LLC | 0.86% | 700,290 | +7.9% | 0.1% | $32,528,000 |
| BANK OF AMERICA CORP /DE/ | 0.8% | 652,898 | +169% | 0% | $30,327,112 |
| FRANKLIN RESOURCES INC | 0.78% | 635,415 | +15% | 0.01% | $29,515,027 |
| GOLDMAN SACHS GROUP INC | 0.73% | 591,711 | +90% | 0% | $27,484,976 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.68% | 549,851 | 0.09% | $25,540,579 | |
| TUDOR INVESTMENT CORP ET AL | 0.64% | 517,813 | +38% | 0.13% | $24,052,414 |
| Walleye Capital LLC | 0.64% | 516,576 | +389% | 0.14% | $23,994,955 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 10,481,554 | $404,109,475 | +$28,962,184 | $38.56 | 61 |
| 2025 Q4 | 50,871,051 | $2,362,926,868 | +$495,868,532 | $46.45 | 181 |
| 2025 Q3 | 35,722,454 | $1,753,301,721 | +$19,824,438 | $49.08 | 145 |
| 2025 Q2 | 34,878,323 | $1,804,950,292 | +$1,802,052,292 | $51.75 | 114 |